PL2415463T3 - Kompozycja lecznicza w postaci cząstek stałych - Google Patents
Kompozycja lecznicza w postaci cząstek stałychInfo
- Publication number
- PL2415463T3 PL2415463T3 PL11711242T PL11711242T PL2415463T3 PL 2415463 T3 PL2415463 T3 PL 2415463T3 PL 11711242 T PL11711242 T PL 11711242T PL 11711242 T PL11711242 T PL 11711242T PL 2415463 T3 PL2415463 T3 PL 2415463T3
- Authority
- PL
- Poland
- Prior art keywords
- medicinal composition
- particulate medicinal
- particulate
- composition
- medicinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010029486A JP4653242B1 (ja) | 2010-02-12 | 2010-02-12 | 粒子状医薬組成物 |
| EP11711242.5A EP2415463B1 (en) | 2010-02-12 | 2011-02-14 | Particulate medicinal composition |
| PCT/JP2011/053052 WO2011099601A1 (ja) | 2010-02-12 | 2011-02-14 | 粒子状医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2415463T3 true PL2415463T3 (pl) | 2016-06-30 |
Family
ID=43952737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15159795T PL2918267T3 (pl) | 2010-02-12 | 2011-02-14 | Kompozycja farmaceutyczna w postaci cząstek stałych |
| PL11711242T PL2415463T3 (pl) | 2010-02-12 | 2011-02-14 | Kompozycja lecznicza w postaci cząstek stałych |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15159795T PL2918267T3 (pl) | 2010-02-12 | 2011-02-14 | Kompozycja farmaceutyczna w postaci cząstek stałych |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9198860B2 (pl) |
| EP (2) | EP2415463B1 (pl) |
| JP (1) | JP4653242B1 (pl) |
| KR (2) | KR101839545B1 (pl) |
| CN (1) | CN102753151B (pl) |
| AU (1) | AU2011215177B2 (pl) |
| CA (1) | CA2785858C (pl) |
| DK (2) | DK2415463T3 (pl) |
| ES (2) | ES2560810T3 (pl) |
| PL (2) | PL2918267T3 (pl) |
| PT (2) | PT2918267T (pl) |
| WO (1) | WO2011099601A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2842546A4 (en) * | 2012-04-27 | 2015-12-30 | Univ Tokyo | PHARMACEUTICAL COMPOSITION WITH UNIT STRUCTURE FOR NUCLEIC ACID RELIEF |
| WO2016137006A1 (ja) * | 2015-02-27 | 2016-09-01 | ナノキャリア株式会社 | ポリマーミセル担体組成物およびポリマーミセル組成物 |
| CN111050752B (zh) | 2017-08-31 | 2022-08-16 | 国立大学法人东京大学 | 搭载核酸的单元型聚离子复合物 |
| JP2024501974A (ja) * | 2020-12-28 | 2024-01-17 | 公益財団法人川崎市産業振興財団 | ポリイオンコンプレックスミセル |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02121932A (ja) * | 1988-10-29 | 1990-05-09 | Res Inst For Prod Dev | ヘモグロビン含有リポソーム、その製造方法および該製造方法用の原液 |
| KR940003548U (ko) * | 1992-08-14 | 1994-02-21 | 김형술 | 세탁물 건조기 |
| FR2759298B1 (fr) * | 1997-02-10 | 1999-04-09 | Rhone Poulenc Rorer Sa | Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees |
| US6884430B1 (en) | 1997-02-10 | 2005-04-26 | Aventis Pharma S.A. | Formulation of stabilized cationic transfection agent(s) /nucleic acid particles |
| JP2002508765A (ja) | 1997-06-23 | 2002-03-19 | アルザ コーポレイション | リポソーム被包ポリヌクレオチド組成物および方法 |
| US6919372B1 (en) | 1997-12-26 | 2005-07-19 | Yamanouchi Pharmaceutical Co., Ltd. | Sustained release pharmaceutical compositions |
| JP2000302685A (ja) * | 1999-02-18 | 2000-10-31 | Sankyo Co Ltd | 抗腫瘍薬含有リポソーム製剤 |
| DE19954843C2 (de) | 1999-11-09 | 2003-11-20 | Novosom Ag | Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung |
| CA2369491C (en) | 2000-02-02 | 2008-09-02 | Yasufumi Kaneda | Virus envelope vector for gene transfer |
| JP3942362B2 (ja) * | 2000-02-02 | 2007-07-11 | アンジェスＭｇ株式会社 | 遺伝子導入のためのウイルスエンベロープベクター |
| FR2814951B1 (fr) * | 2000-10-06 | 2003-01-17 | Flamel Tech Sa | Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation |
| JP4063510B2 (ja) * | 2001-07-13 | 2008-03-19 | ナノキャリア株式会社 | 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤 |
| ATE345780T1 (de) | 2001-07-13 | 2006-12-15 | Nanocarrier Co Ltd | Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung |
| JP4294946B2 (ja) * | 2002-12-13 | 2009-07-15 | 富士フイルム株式会社 | 標的検出装置及び標的検出方法並びに標的検出用基材 |
| US7521187B2 (en) * | 2002-12-23 | 2009-04-21 | Vical Incorporated | Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes |
| CA2559029A1 (en) | 2004-03-10 | 2005-10-06 | Kyowa Hakko Kogyo Co., Ltd. | Complex particles and coated complex particles |
| EP1773857A4 (en) | 2004-07-02 | 2009-05-13 | Protiva Biotherapeutics Inc | THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF |
| WO2006060723A2 (en) * | 2004-12-03 | 2006-06-08 | Vical Incorporated | Methods for producing block copolymer/amphiphilic particles |
| JP2006321763A (ja) * | 2005-05-20 | 2006-11-30 | Hosokawa Funtai Gijutsu Kenkyusho:Kk | 生体適合性ナノ粒子及びその製造方法 |
| JP2007099631A (ja) * | 2005-09-30 | 2007-04-19 | Hosokawa Funtai Gijutsu Kenkyusho:Kk | アニオン性薬物封入ナノ粒子の製造方法及びそれを用いた医薬製剤 |
| KR20080064827A (ko) * | 2005-10-05 | 2008-07-09 | 도쿄 씨알오 가부시키가이샤 | 생체 적합성 블록 공중합체, 그 용도 및 제조법 |
| WO2007136134A1 (ja) * | 2006-05-23 | 2007-11-29 | Nanocarrier Co., Ltd. | 疎水性薬物内包ポリマーミセルの製造方法 |
| KR101363498B1 (ko) * | 2006-07-18 | 2014-02-14 | 나노캬리아 가부시키가이샤 | 생리활성 폴리펩티드 또는 단백질 내포 고분자 폴리머 미셀및 그 제조방법 |
| US20080311040A1 (en) * | 2007-03-06 | 2008-12-18 | Flagship Ventures | METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA |
| JP2009200681A (ja) | 2008-02-20 | 2009-09-03 | Seiko Instruments Inc | 近接検出装置および近接検出方法 |
| WO2010074540A2 (ko) * | 2008-12-26 | 2010-07-01 | 주식회사 삼양사 | 음이온성 약물 함유 약제학적 조성물 및 그 제조방법 |
-
2010
- 2010-02-12 JP JP2010029486A patent/JP4653242B1/ja not_active Expired - Fee Related
-
2011
- 2011-02-14 EP EP11711242.5A patent/EP2415463B1/en not_active Not-in-force
- 2011-02-14 DK DK11711242.5T patent/DK2415463T3/en active
- 2011-02-14 ES ES11711242.5T patent/ES2560810T3/es active Active
- 2011-02-14 PL PL15159795T patent/PL2918267T3/pl unknown
- 2011-02-14 DK DK15159795.2T patent/DK2918267T3/en active
- 2011-02-14 CA CA2785858A patent/CA2785858C/en not_active Expired - Fee Related
- 2011-02-14 KR KR1020167008609A patent/KR101839545B1/ko not_active Expired - Fee Related
- 2011-02-14 ES ES15159795.2T patent/ES2636778T3/es active Active
- 2011-02-14 KR KR1020127017814A patent/KR101612876B1/ko not_active Expired - Fee Related
- 2011-02-14 CN CN201180009063.8A patent/CN102753151B/zh not_active Expired - Fee Related
- 2011-02-14 EP EP15159795.2A patent/EP2918267B1/en not_active Not-in-force
- 2011-02-14 AU AU2011215177A patent/AU2011215177B2/en not_active Ceased
- 2011-02-14 US US13/122,546 patent/US9198860B2/en not_active Expired - Fee Related
- 2011-02-14 PT PT151597952T patent/PT2918267T/pt unknown
- 2011-02-14 PT PT117112425T patent/PT2415463E/pt unknown
- 2011-02-14 WO PCT/JP2011/053052 patent/WO2011099601A1/ja not_active Ceased
- 2011-02-14 PL PL11711242T patent/PL2415463T3/pl unknown
-
2015
- 2015-11-02 US US14/930,119 patent/US9795563B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011215177A1 (en) | 2012-07-05 |
| US9795563B2 (en) | 2017-10-24 |
| EP2918267B1 (en) | 2017-05-10 |
| PT2415463E (pt) | 2016-03-22 |
| JP4653242B1 (ja) | 2011-03-16 |
| ES2636778T3 (es) | 2017-10-09 |
| WO2011099601A1 (ja) | 2011-08-18 |
| KR20120113754A (ko) | 2012-10-15 |
| CN102753151B (zh) | 2014-08-06 |
| DK2415463T3 (en) | 2016-04-11 |
| DK2918267T3 (en) | 2017-07-10 |
| EP2918267A1 (en) | 2015-09-16 |
| ES2560810T3 (es) | 2016-02-22 |
| KR101612876B1 (ko) | 2016-04-18 |
| PL2918267T3 (pl) | 2017-09-29 |
| EP2415463A4 (en) | 2012-02-29 |
| KR20160041057A (ko) | 2016-04-15 |
| AU2011215177B2 (en) | 2015-10-15 |
| US9198860B2 (en) | 2015-12-01 |
| KR101839545B1 (ko) | 2018-03-16 |
| EP2415463B1 (en) | 2016-01-13 |
| US20160058703A1 (en) | 2016-03-03 |
| JP2011162512A (ja) | 2011-08-25 |
| EP2415463A1 (en) | 2012-02-08 |
| PT2918267T (pt) | 2017-06-22 |
| CA2785858A1 (en) | 2011-08-18 |
| CN102753151A (zh) | 2012-10-24 |
| US20120076866A1 (en) | 2012-03-29 |
| CA2785858C (en) | 2016-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL245326B (en) | pharmaceutical preparation | |
| SI2619182T1 (sl) | Farmacevtski sestavek | |
| IL225457A0 (en) | Pharmaceutical composition | |
| ZA201304189B (en) | Novel pharmaceutical composition | |
| PT2579858E (pt) | Composição farmacêutica que contém ivabradina | |
| ZA201301920B (en) | Pharmaceutical composition | |
| GB201010453D0 (en) | Pharmaceutical composition | |
| IL226554A (en) | Medicinal preparations containing alisporiovir | |
| PT2415463E (pt) | Composição medicinal em partículas | |
| IL221501A (en) | Medicinal product containing miramistine | |
| EP2560678A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB201001911D0 (en) | Pharmaceutical composition | |
| GB201019775D0 (en) | Pharmaceutical composition | |
| HU1000006D0 (en) | Improved pharmaceutical composition |